8-K · 2026-11-12
Parabilis Medicines, Inc. announces its financial results for Q3 2026, showcasing developments in its operations and implications for the pharmaceutical industry.
| Name | Parabilis Medicines, Inc. |
|---|---|
| CIK | 0001657677 |
| Tickers | PBLS |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 474505725 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 617-945-9510 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Parabilis Medicines, Inc. announces its financial results for Q3 2026, showcasing developments in its operations and implications for the pharmaceutical industry.
65 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-12 | 10-Q | 10-Q | 0001193125-26-458388 | 001-43331 | 261547042 | 34 | 13299238 | 1 | 1 | |
| 2026-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-456892 | 001-43331 | 261543111 | 34 | 633626 | 1 | 1 |
| 2026-11-05 | 8-K | 8-K | 1.01 | 0001193125-26-449869 | 001-43331 | 261527537 | 34 | 166362 | 1 | 1 |
| 2026-09-15 | 8-K | 8-K | 7.01 | 0001193125-26-391952 | 001-43331 | 261380977 | 34 | 159976 | 1 | 1 |
| 2026-09-02 | 8-K | 8-K | 5.02 | 0001193125-26-380171 | 001-43331 | 261354721 | 34 | 162453 | 1 | 1 |
| 2026-08-25 | 4 | 4 | 0001193125-26-365484 | 5484 | ||||||
| 2026-08-25 | 3 | 3 | 0001193125-26-365459 | 19551 | ||||||
| 2026-08-25 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-26-365132 | 001-43331 | 261315808 | 34 | 310393 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-352189 | 005-95761 | 261281153 | 34 | 34144 | |||
| 2026-08-13 | 10-Q | 10-Q | 0001193125-26-349168 | 001-43331 | 261273318 | 34 | 12038891 | 1 | 1 | |
| 2026-08-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-347869 | 001-43331 | 261270025 | 34 | 18884016 | 1 | 1 |
| 2026-08-06 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002123 | 005-95761 | 261247193 | 34 | 11684 | |||
| 2026-07-22 | 4 | xslF345X06/form4-07222026_080742.xml | 0001231919-26-000779 | 25016 | ||||||
| 2026-06-29 | 4 | xslF345X06/ownership.xml | 0001213900-26-072928 | 28040 | ||||||
| 2026-06-29 | 3 | xslF345X06/ownership.xml | 0001213900-26-072925 | 15123 | ||||||
| 2026-06-18 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001346824-26-000178 | 005-95761 | 261102607 | 34 | 27623 | |||
| 2026-06-16 | 4 | 4 | 0001193125-26-273013 | 9612 | ||||||
| 2026-06-15 | 4 | xslF345X06/form4-06152026_100639.xml | 0001231919-26-000638 | 27432 | ||||||
| 2026-06-15 | 4 | 4 | 0001193125-26-271344 | 14669 | ||||||
| 2026-06-15 | 4 | 4 | 0001193125-26-271324 | 5477 | ||||||
| 2026-06-15 | 4 | 4 | 0001193125-26-271300 | 7129 | ||||||
| 2026-06-11 | 4 | xslF345X06/e665575_4-pbls.xml | 0001193805-26-000798 | 55923 | ||||||
| 2026-06-11 | 4 | xslF345X06/form4-06112026_100601.xml | 0001231919-26-000623 | 14399 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267806 | 5567 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267802 | 5560 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267797 | 5575 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267769 | 5574 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267766 | 5573 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267747 | 5522 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267733 | 5482 | ||||||
| 2026-06-11 | 8-K | 8-K | 1.01,3.02,5.03,9.01 | 0001193125-26-267550 | 001-43331 | 261083157 | 34 | 639186 | 1 | 1 |
| 2026-06-10 | S-8 | S-8 | 0001193125-26-266037 | 333-296683 | 261080563 | 33 | 351907 | 1 | 1 | |
| 2026-06-10 | 424B4 | 424B4 | 0001193125-26-265983 | 333-296032 | 261080385 | 33 | 23163695 | |||
| 2026-06-10 | FWP | FWP | 0001193125-26-264521 | 333-296032 | 261077731 | 34 | 22130 | |||
| 2026-06-09 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001929 | 333-296032 | 261077892 | 33 | 1862 | ||
| 2026-06-09 | 3 | xslF345X06/form3-06102026_010620.xml | 0001231919-26-000614 | 17182 | ||||||
| 2026-06-09 | 3 | 3 | 0001193125-26-264599 | 22205 | ||||||
| 2026-06-09 | 3 | 3 | 0001193125-26-264596 | 16876 | ||||||
| 2026-06-09 | 3 | 3 | 0001193125-26-264592 | 20696 | ||||||
| 2026-06-09 | 3 | 3 | 0001193125-26-264589 | 16780 | ||||||
| 2026-06-09 | 3 | xslF345X06/e665567_3-pbls.xml | 0001193805-26-000786 | 32900 | ||||||
| 2026-06-09 | 3 | 3 | 0001193125-26-264583 | 19650 | ||||||
| 2026-06-09 | 3 | 3 | 0001193125-26-264578 | 19343 | ||||||
| 2026-06-09 | 3 | 3 | 0001193125-26-264575 | 18383 | ||||||
| 2026-06-09 | 3 | 3 | 0001193125-26-264573 | 24673 | ||||||
| 2026-06-09 | 3 | 3 | 0001193125-26-264567 | 19647 | ||||||
| 2026-06-09 | 3 | 3 | 0001193125-26-264563 | 16539 | ||||||
| 2026-06-09 | 3 | 3 | 0001193125-26-264556 | 18219 | ||||||
| 2026-06-09 | 3 | 3 | 0001193125-26-264550 | 20697 | ||||||
| 2026-06-09 | 3 | 3 | 0001193125-26-264547 | 21102 | ||||||
| 2026-06-09 | S-1MEF | S-1MEF | 0001193125-26-264426 | 333-296655 | 261077513 | 33 | 281303 | |||
| 2026-06-09 | CERT | 8A_Cert_PBLS_0001657677.pdf | 0001354457-26-000549 | 001-43331 | 261075379 | 34 | 180985 | |||
| 2026-06-09 | S-1/A | S-1/A | 0001193125-26-262880 | 333-296032 | 261074508 | 33 | 23582034 | |||
| 2026-06-05 | 8-A12B | 8-A12B | 0001193125-26-259552 | 001-43331 | 261069112 | 34 | 39987 | |||
| 2026-06-04 | S-1/A | S-1/A | 0001193125-26-256398 | 333-296032 | 261063132 | 33 | 25560953 | |||
| 2026-05-27 | S-1/A | S-1/A | 0001193125-26-242067 | 333-296032 | 261027222 | 33 | 12880501 | |||
| 2026-05-19 | S-1 | S-1 | 0001193125-26-230994 | 333-296032 | 26999901 | 33 | 26409346 | 1 | 1 | |
| 2026-04-02 | DRS | filename1.htm | 0001193125-26-140488 | 377-09210 | 26835286 | 33 | 13671006 | |||
| 2022-12-02 | D | xslFormDX01/primary_doc.xml | 06b | 0001657677-22-000001 | 021-466472 | 221442695 | 33 | 11957 | ||
| 2021-01-05 | D | xslFormDX01/primary_doc.xml | 06b | 0001657677-21-000002 | 021-385216 | 21504241 | 33 | 11076 | ||
| 2018-05-16 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001657677-18-000003 | 021-305650 | 18839620 | 33 | 9433 | ||
| 2018-02-14 | D | xslFormDX01/primary_doc.xml | 06b | 0001657677-18-000002 | 021-305650 | 18611980 | 33 | 9340 | ||
| 2017-08-22 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001657677-17-000001 | 021-264481 | 171045625 | 33 | 8688 | ||
| 2016-06-07 | D | xslFormDX01/primary_doc.xml | 06b | 0001657677-16-000004 | 021-264481 | 161700417 | 33 | 7586 | ||
| 2015-11-13 | D | xslFormDX01/primary_doc.xml | 06b | 0001657677-15-000002 | 021-251210 | 151228433 | 33 | 6085 |
One latest value per concept from companyfacts (161 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ffd | NetFeeAmt | NetFeeAmt | USD | 25,145.71 | 2026-06-09 | S-1/A | 2026-06-09 | 0001193125-26-262880 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 100,582.83 | 2026-06-09 | S-1/A | 2026-06-09 | 0001193125-26-262880 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 728.33M | 2026-06-09 | S-1/A | 2026-06-09 | 0001193125-26-262880 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-06-09 | S-1/A | 2026-06-09 | 0001193125-26-262880 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 75,437.12 | 2026-06-09 | S-1/A | 2026-06-09 | 0001193125-26-262880 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 20.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 443,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 2.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 8.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 24.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 14.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -1.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 1.69B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 7.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 15.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | Assets | Assets | USD | 1.13B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 879.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 277,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-349168 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 521.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 524.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 493.49M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 27.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 600.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 122.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 122.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 12,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -144.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 814.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ConversionOfStockAmountIssued1 | Conversion of Stock, Amount Issued | USD | 55.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ConversionOfStockSharesConverted1 | Conversion of Stock, Shares Converted | shares | 2.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | DebtCurrent | Debt, Current | USD | 2.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 15.00M | 2021-09-21 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 543.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | USD | 1.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | DebtSecuritiesHeldToMaturityTransferToAvailableForSaleAllowanceForCreditLossExpense | Debt Securities, Held-to-Maturity, Transfer to Available-for-Sale, Allowance for Credit Loss, Expense | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | DeferredCostsCurrent | Deferred Costs, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 5.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 13.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 27.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 1.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 1.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 1.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | DividendIncomeOperating | Dividend Income, Operating | USD | 7.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -3.51 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -3.51 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 27.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | USD | 0 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 684,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 951,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 473,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | FinanceLeaseRightOfUseAsset | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | USD | 2.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | FinanceLeaseRightOfUseAssetAccumulatedAmortization | Finance Lease, Right-of-Use Asset, Accumulated Amortization | USD | 1.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | FinanceLeaseRightOfUseAssetAmortization | Finance Lease, Right-of-Use Asset, Amortization | USD | 400,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | FurnitureAndFixturesGross | Furniture and Fixtures, Gross | USD | 609,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 32.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 443,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 40.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | IncreaseDecreaseInDueFromRelatedParties | Increase (Decrease) in Due from Related Parties | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -5.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | USD | 3.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 7.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | IncrementalCommonSharesAttributableToContingentlyIssuableShares | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares | shares | 419,506 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 626,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 16.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 520,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 5.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | Liabilities | Liabilities | USD | 126.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 1.13B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 68.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | LineOfCreditFacilityCommitmentFeePercentage | Line of Credit Facility, Commitment Fee Percentage | pure | 0.5 | 2024-11-01 | 2024-11-22 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | LineOfCreditFacilityMaximumBorrowingCapacity | Line of Credit Facility, Maximum Borrowing Capacity | USD | 60.00M | 2024-11-22 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | LongTermDebtAndCapitalLeaseObligationsCurrent | Long-term Debt and Lease Obligation, Current | USD | 750,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 2.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 700,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-349168 | |
| us-gaap | MachineryAndEquipmentGross | Machinery and Equipment, Gross | USD | 936,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 551.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 350.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 201.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | NetAssetValuePerShare | Net Asset Value Per Share | USD/shares | 1 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 1.14B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -552.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -93.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -142.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -182.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 10.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 155.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -153.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 7.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 30.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 34.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 4.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | OtherAssets | Other Assets | USD | 4.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax | USD | -1.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | OtherLiabilities | Other Liabilities | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | PaymentsForCommissions | Payments for Commissions | USD | 57.60M | 2026-06-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | PaymentsForRepurchaseOfInitialPublicOffering | Payments for Repurchase of Initial Public Offering | USD | 5.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 11.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 680,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 560.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 1.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | PreferredStockConvertibleDownRoundFeatureIncreaseDecreaseInEquityAmount1 | PreferredStockConvertibleDownRoundFeatureIncreaseDecreaseInEquityAmount1 | USD | -7.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | PreferredStockNoParValue | Preferred Stock, No Par Value | USD/shares | 6.43 | 2024-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 6.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 718.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 712.90M | 2026-06-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 811.80M | 2026-06-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 15.00M | 2026-06-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 83.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 1.60M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 9.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 1.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -142.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 24.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 9.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 122.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 2.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 524.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -683.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | Revenues | Revenues | USD | 2.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | SaleOfStockConsiderationReceivedPerTransaction | Sale of Stock, Consideration Received Per Transaction | USD | 50.00M | 2026-06-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 7.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.92 | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.037 | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 205.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 7.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 2.97 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 7.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 904,734 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 7.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 3.89 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 437.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 15.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 3.98 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 437.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 15.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 3.98 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 1.85 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 2.47 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 5.22 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | ShortTermBorrowings | Short-term Debt | USD | 1.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 1.00B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 559,167 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 814.54M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 712.89M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 2.74M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 262,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | TradingSecuritiesDebtAmortizedCost | Debt Securities, Trading, Amortized Cost | USD | 553.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | UnamortizedDebtIssuanceExpense | Unamortized Debt Issuance Expense | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 | |
| us-gaap | UnrealizedGainLossOnPriceRiskFairValueHedgingInstruments | Unrealized Gain (Loss) on Price Risk Fair Value Hedging Instruments | USD | 33.60M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-349168 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 51.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 51.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458388 |